Focal Segmental Glomerulosclerosis Recurrence: Soluble Urokinase Receptor Left Out?

Transplantation. 2015 Dec;99(12):2449-50. doi: 10.1097/TP.0000000000000923.

Authors

Guillaume Canaud¹, Alexandre Loupy

Affiliation

¹ 1 Université Paris Descartes, Rue de l'Ecole de Médecine, Paris, France. 2 Service de Néphrologie et Transplantation, Hôpital Necker, Paris, France. 3 Institut National de la Recherche U1151, Hôpital Necker, Paris, France. 4 Paris Translational Research Center for Organ Transplantation and Cardiovascular Disease, Paris, France.

PMID: 26371599
DOI: 10.1097/TP.0000000000000923

No abstract available

Publication types

Comment

MeSH terms

Female
Glomerulosclerosis, Focal Segmental / therapy*
Humans
Integrin beta3 / metabolism*
Male
Monitoring, Physiologic / methods*
Plasma Exchange / methods*
Podocytes / metabolism*
Receptors, Urokinase Plasminogen Activator / metabolism*

Substances

Integrin beta3
Receptors, Urokinase Plasminogen Activator